That Was Quick! FDA Approves New Intravenous Monkeypox Drug Treatment From PFIZER-Linked SIGA Technologies
The Gateway Pundit ^ | May 20, 2022 | Julian Conradson
Posted on 5/20/2022, 10:19:35 PM by Macho MAGA Man
Pfizer is apparently at it again, conveniently hitting another grand slam with another perfectly timed drug release for the latest viral outbreak sweeping the west – monkeypox.
After hitting it out of the park with their experimental mRNA Covid vaccine – typically what would be considered a once-in-a-lifetime development that's cashing the company out to a tune of $1,000 per second – it seems like a long stretch that Pfizer would be involved in the ‘cure’ for the new outbreak, but hey, they apparently pulled it off.
Either way, here comes a Pfizer affiliate with another healthcare ‘solution’ as monkeypox becomes the new Covid.
On Thursday, the US Food and Drug Administration (FDA) announced that it had approved the company's intravenous version of TPOXX® (tecovirimat) for use in the US to treat monkeypox. The new drug was created by SIGA Technologies, which formed a partnership related to the drug with Meridian Medical Technologies in 2019.
And, sure enough, Meridian is owned by Pfizer.
Amazing!